Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Baricitinib improved hair loss and arthritis in a lupus patient.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Nilotinib can cause skin issues like red bumps and hair loss.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.